Search - tctmd.com

Displaying 481 - 500 of 1576

Sort: Relevancy | Date

Presentation TCT 2017

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada

October 30, 2017

Presentation TCT 2017

Case Presentation: My Worst Bifurcation Mistake

Presenter: Antonio Colombo, Manuel Pan, Azeem Latib

October 30, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Case Presentation: My Worst Bifurcation Mistake

Presenter: Antonio Colombo, Manuel Pan

October 30, 2017

Presentation TCT 2017

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Roxana Mehran

October 30, 2017

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

Presentation TCT 2017

Ulnar Approach: Ipsilateral, Contralateral, or Never?

Presenter: Binita Shah, Adhir Shroff, Rajiv Gulati

October 30, 2017

Presentation TCT 2017

Reasonable and Unreasonable Bifurcations for Bioresorbable Scaffolds, and Technique (With Case Examples)

Presenter: Antonio Colombo, Manuel Pan, Jens Flensted Lassen

October 30, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Thomas Engstroem

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Presentation TCT 2017

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Presenter: Antonio Colombo, Manuel Pan, Jozica Sikic

October 30, 2017

Presentation TCT 2017

Transradial Slender Approach

Presenter: Binita Shah, Adhir Shroff, Shigeru Saito

October 30, 2017

Presentation TCT 2017

Switching to and From Cangrelor: When and How?

Presenter: Dominick J. Angiolillo, Marco Valgimigli

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

How to Treat the Medina 0,0,1 Lesion

Presenter: Antonio Colombo, Manuel Pan, Angela Hoye

October 30, 2017

Presentation TCT 2017

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Presenter: Dominick J. Angiolillo, Marco Valgimigli, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller

October 30, 2017

Presentation TCT 2017

Distal Radial Access: New Paradigm in Radial Approach

Presenter: Binita Shah, Adhir Shroff, Ian C. Gilchrist

October 30, 2017

Presentation TCT 2017

Case Presentation: Why I Lost This Branch and What I Should Have Done Instead

Presenter: Antonio Colombo, Manuel Pan, Hyeon-Cheol Gwon

October 30, 2017

Advertisement

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Case Presentation: My Worst Bifurcation Mistake

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Case Presentation: My Worst Bifurcation Mistake

Rationale and Studies of P2Y12 Inhibitor Monotherapy

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Ulnar Approach: Ipsilateral, Contralateral, or Never?

Reasonable and Unreasonable Bifurcations for Bioresorbable Scaffolds, and Technique (With Case Examples)

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Transradial Slender Approach

Switching to and From Cangrelor: When and How?

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

How to Treat the Medina 0,0,1 Lesion

Switching Between Oral P2Y12 Receptor Inhibitors: When and How?

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Distal Radial Access: New Paradigm in Radial Approach

Case Presentation: Why I Lost This Branch and What I Should Have Done Instead

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content